Press release
Diabetic Neuropathy Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Serodus, Novartis, Curacle Co., Ltd, Sonnet BioTherapeutics, Inc., Teijin America, Inc., Shangha
Diabetic Neuropathy Pipeline constitutes 20+ key companies continuously working towards developing 25+ Diabetic Neuropathy treatment therapies, analyzes DelveInsight.Diabetic Neuropathy Overview:
Diabetic neuropathy is a form of nerve damage that develops in individuals with diabetes, particularly those with prolonged poor blood sugar control. It primarily affects the peripheral nerves, which are responsible for sensation and movement in the limbs. There are several types of diabetic neuropathy, including peripheral neuropathy (impacting the hands and feet), autonomic neuropathy (affecting internal organs), proximal neuropathy (causing issues in the thighs, hips, or buttocks), and focal neuropathy (targeting a specific nerve).
The symptoms of diabetic neuropathy vary based on the type and severity of nerve damage. Peripheral neuropathy commonly causes tingling, numbness, or pain in the extremities, which can worsen over time, leading to loss of sensation and movement difficulties. Autonomic neuropathy may result in digestive problems, urinary issues, sexual dysfunction, and heart-related complications. Proximal neuropathy often presents as pain in the thighs, hips, or buttocks, while focal neuropathy leads to sudden, localized pain or weakness in a specific nerve.
Request for a detailed insights report on Diabetic Neuropathy pipeline insights @ https://www.delveinsight.com/report-store/diabetic-neuropathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
"Diabetic Neuropathy Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Diabetic Neuropathy Therapeutics Market.
Key Takeaways from the Diabetic Neuropathy Pipeline Report
DelveInsight's Diabetic Neuropathy pipeline report depicts a robust space with 20+ active players working to develop 25+ pipeline therapies for Diabetic Neuropathy treatment.
Key Diabetic Neuropathy companies such as Serodus, Novartis, Curacle Co., Ltd, Sonnet BioTherapeutics, Inc., Teijin America, Inc., Shanghai Pharmaceuticals Holding Co., Ltd, ChemoCentryx, Roche, Cyclerion Therapeutics, Inversago Pharma Inc, Sunshine Lake Pharma Co., Ltd., Goldfinch Bio, Cosette Pharmaceuticals, Boehringer Ingelheim, Chinook Therapeutics, and others are evaluating new drugs for Diabetic Neuropathy to improve the treatment landscape.
Promising Diabetic Neuropathy pipeline therapies in various stages of development include SER 150, LMB-763, CU01, and others.
Recent breakthroughs in the Diabetic Neuropathy Pipeline Segment:
In January 2024, Neuralace Medical received FDA clearance for Axon Therapy, a non-invasive magnetic peripheral nerve stimulation (mPNS) treatment for chronic painful diabetic neuropathy (PDN). This therapy delivers painless magnetic pulses during 13.5-minute sessions, offering a novel approach to pain management. A double-blind, multicenter randomized controlled trial demonstrated a 72.3% responder rate and a 57.6% average reduction in pain scores at 30 days. By 90 days, responder rates increased to 81.4% in the treatment group.
Diabetic Neuropathy Pipeline Analysis
The report provides insights into:
The report provides detailed insights into the key companies that are developing therapies in the Diabetic Neuropathy Market.
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Diabetic Neuropathy treatment.
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Diabetic Neuropathy market.
Download our free sample page report on Diabetic Neuropathy pipeline insights @ https://www.delveinsight.com/sample-request/diabetic-neuropathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Diabetic Neuropathy Emerging Drugs
SER 150: Serodus
LMB-763: Novartis
CU01: Curacle Co., Ltd
Diabetic Neuropathy Companies
More than 20 key companies are actively developing therapies for Diabetic Neuropathy. Among them, Serodus has a drug candidate in the most advanced stage of development, specifically in Phase II/III clinical trials.
DelveInsight's report covers around 25+ products under different phases of clinical development like
Late stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Diabetic Neuropathy pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
Intravenous
Subcutaneous
Oral
Intramuscular
Diabetic Neuropathy Products have been categorized under various Molecule types such as
Monoclonal antibody
Small molecule
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Diabetic Neuropathy Therapies and Key Companies: Diabetic Neuropathy Clinical Trials and advancements @ https://www.delveinsight.com/report-store/diabetic-neuropathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Diabetic Neuropathy Pipeline Therapeutic Assessment
• Diabetic Neuropathy Assessment by Product Type
• Diabetic Neuropathy By Stage
• Diabetic Neuropathy Assessment by Route of Administration
• Diabetic Neuropathy Assessment by Molecule Type
Download Diabetic Neuropathy Sample report to know in detail about the Diabetic Neuropathy treatment market @ Diabetic Neuropathy Therapeutic Assessment @ https://www.delveinsight.com/sample-request/diabetic-neuropathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Diabetic Neuropathy Current Treatment Patterns
4. Diabetic Neuropathy - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Diabetic Neuropathy Late-Stage Products (Phase-III)
7. Diabetic Neuropathy Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Diabetic Neuropathy Discontinued Products
13. Diabetic Neuropathy Product Profiles
14. Diabetic Neuropathy Key Companies
15. Diabetic Neuropathy Key Products
16. Dormant and Discontinued Products
17. Diabetic Neuropathy Unmet Needs
18. Diabetic Neuropathy Future Perspectives
19. Diabetic Neuropathy Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Diabetic Neuropathy Pipeline Reports Offerings: https://www.delveinsight.com/report-store/diabetic-neuropathy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Contact Info:
Kritika Rehani
krehani@delveinsight.com
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Neuropathy Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Serodus, Novartis, Curacle Co., Ltd, Sonnet BioTherapeutics, Inc., Teijin America, Inc., Shangha here
News-ID: 3936999 • Views: …
More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…

Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…

Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…

Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Diabetic
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Leading Element Driving Change in the Diabetic Footwear Market in 2025: Rising D …
Which drivers are expected to have the greatest impact on the over the diabetic footwear market's growth?
The surge in people with diabetes will spur the expansion of the diabetic footwear market in the future. Diabetes, characterised by high blood sugar levels, is a long-term health issue. Diabetic footwear can prevent severe foot-related issues caused by diabetes and offer several advantages such as enhanced blood flow, ample space for the toes,…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…